| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry, Cancer Institute, Kami-ikebukuro, Toshima-ku, Tokyo 170, Japan [R. M., S. S., K. Y., Y. N.]; Department of Genetics Research Laboratory, SRL, Inc., Komiya-machi, Hachioji City, Tokyo 192, Japan [R. M., S. S.]; Center for Biotechnology, Baylor College of Medicine, Woodlands, Texas 77381 [J. I.]; and Department of Urology, Faculty of Medicine, Kyoto University, Shogoin-kawahara-cho 54, Sakyo-ku, Kyoto 606, Japan [O. O., O. Y.]
Relatively frequent losses of heterozygosity on chromosomes 5q, 6q, and 10q, in addition to loss of heterozygosity on the short arm of chromosome 3, have been observed in renal cell carcinomas. As the first step toward isolation of tumor suppressor genes on these three chromosomal arms, we used six restriction fragment length polymorphism markers for 5q, nine for 6q, and eight for 10q to identify regions commonly deleted in a panel of 64 renal cell carcinomas. Allelic losses were common at chromosome 5q21, the region where the MCC (mutated in colorectal cancer) gene was recently identified; at chromosome 6q27; and at chromosome 10q21-23. Furthermore, an association was observed between accumulation of allelic losses on these three chromosomal arms and progression of tumors. Loss of heterozygosity on chromosome 5 showed a correlation with the histopathological grade of a given tumor and the incidence of distant metastasis.
1 To whom requests for reprints should be addressed, at Department of Biochemistry, Cancer Institute, 1-37-1, Kami-ikebukuro, Toshima-ku, Tokyo 170, Japan.
Received 6/19/91. Accepted 8/13/91.
This article has been cited by other articles:
|
|
 |
|
  M. C. Picchio, E. S. Martin, R. Cesari, G. A. Calin, S. Yendamuri, T. Kuroki, F. Pentimalli, M. Sarti, K. Yoder, L. R. Kaiser, et al. Alterations of the Tumor Suppressor Gene Parkin in Non-Small Cell Lung Cancer Clin. Cancer Res., April 15, 2004; 10(8): 2720 - 2724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Reiss, B. Oskouian, J. Zhou, V. Gupta, P. Sooriyakumaran, S. Kelly, E. Wang, A. H. Merrill Jr., and J. D. Saba Sphingosine-phosphate Lyase Enhances Stress-induced Ceramide Generation and Apoptosis J. Biol. Chem., January 9, 2004; 279(2): 1281 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Cesari, E. S. Martin, G. A. Calin, F. Pentimalli, R. Bichi, H. McAdams, F. Trapasso, A. Drusco, M. Shimizu, V. Masciullo, et al. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27 PNAS, May 13, 2003; 100(10): 5956 - 5961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Trapani, V. R. Sutton, K. Y.T. Thia, Y. Q. Li, C. J. Froelich, D. A. Jans, M. S. Sandrin, and K. A. Browne A clathrin/dynamin- and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death J. Cell Biol., January 21, 2003; 160(2): 223 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zhou, A. Zettl, P. Strobel, K. Wagner, H. K. Muller-Hermelink, S.-j. Zhang, A. Marx, and P. Starostik Thymic Epithelial Tumors Can Develop along Two Different Pathogenetic Pathways Am. J. Pathol., November 1, 2001; 159(5): 1853 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Jiang, R. Desper, C. H. Papadimitriou, A. A. Schäffer, O.-P. Kallioniemi, J. Richter, P. Schraml, G. Sauter, M. J. Mihatsch, and H. Moch Construction of Evolutionary Tree Models for Renal Cell Carcinoma from Comparative Genomic Hybridization Data Cancer Res., November 1, 2000; 60(22): 6503 - 6509. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. A. Little, N. D. Hastie, and R. C. Davies Identification of WTAP, a novel Wilms' tumour 1-associating protein Hum. Mol. Genet., September 1, 2000; 9(15): 2231 - 2239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schneider, S. Borgnat, H. Lang, O. Régine, V. Lindner, M. Kassem, C. Saussine, P. Oudet, D. Jacqmin, and M. P. Gaub Evaluation of Microsatellite Analysis in Urine Sediment for Diagnosis of Bladder Cancer Cancer Res., August 1, 2000; 60(16): 4617 - 4622. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Starostik, A. Greiner, A. Schultz, A. Zettl, K. Peters, A. Rosenwald, M. Kolve, and H. K. Muller-Hermelink Genetic aberrations common in gastric high-grade large B-cell lymphoma Blood, February 15, 2000; 95(4): 1180 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Merup, T. C. Moreno, M. Heyman, K. Ronnberg, D. Grander, R. Detlofsson, O. Rasool, Y. Liu, S. Soderhall, G. Juliusson, et al. 6q Deletions in Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphomas Blood, May 1, 1998; 91(9): 3397 - 3400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Srivastava, L. Bubendorf, V. Srikantan, L. Fossom, L. Nolan, M. Glasman, X. Leighton, W. Fehrle, S. Pittaluga, M. Raffeld, et al. ANX7, a candidate tumor suppressor gene for prostate cancer PNAS, April 10, 2001; 98(8): 4575 - 4580. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
